Hyderabad vs Pune for Pharma and Life Sciences GCCs: a side by side comparison
Hyderabad has Genome Valley and the world headquarters of two Indian pharma majors. Pune has the deepest finance and clinical analytics talent. The right answer depends on what you actually want to build.
Hyderabad has Genome Valley and the world headquarters of two Indian pharma majors. Pune has the deepest finance and clinical analytics talent. The right answer depends on what you actually want to build.
Pharma GCCs in India are no longer a Bangalore conversation. The two cities that matter for new pharma and life sciences captives are Hyderabad and Pune. Each wins different parts of the value chain and the wrong choice locks you into a 7 year correction.
Where Hyderabad wins
- Genome Valley is the only built-out life sciences cluster in India with wet lab infrastructure, biosafety BSL-2 and BSL-3 capacity, and shared instrumentation
- Dr Reddy's, Aurobindo, Divi's and Hetero headquarters create a deep pool of formulation, API and regulatory talent
- Lower real estate cost than Bangalore and Pune at comparable Grade A specification
- Telangana government runs the most active pharma single-window in India
- CSIR-CCMB and IICT provide a research adjacency Bangalore lacks
Where Pune wins
- Deepest finance and FP&A talent for pharma controllership and revenue analytics
- Clinical data management, biostatistics and SAS programming talent at scale through Symbiosis, BVDU and ILS
- Stronger IT and engineering adjacency for digital therapeutics, medical device software and pharma SaaS
- Lower attrition (16 to 19% vs Hyderabad 20 to 24%) suits multi year clinical programs
- Better European cultural fit; most German, Swiss and Nordic pharma parents prefer Pune
The split by function
- Wet lab, formulation, regulatory CMC, API and biologics R&D: Hyderabad almost always
- Clinical operations, biostatistics, pharmacovigilance, medical writing: Pune wins on talent depth
- Finance, FP&A, commercial analytics, master data: Pune
- Digital health, medtech software, AI for drug discovery: split, but Pune for the European and Japanese parents
What we tell clients in 2026
If you are a US or Indian pharma parent setting up an R&D focused captive, Hyderabad is the default. If you are a European, Japanese or US pharma parent setting up a finance, clinical operations or digital captive, Pune is the default. If you are doing both, the dual city model works because BLR to HYD is a one hour flight and Pune to HYD is two hours. Run the wet lab function in Hyderabad and everything else in Pune.
The cost picture
Hyderabad lab space runs 25 to 35% cheaper than Bangalore equivalents. Pune Grade A office is 30 to 40% below Bangalore. Talent cost for a senior clinical data manager is roughly flat across the two cities; for a regulatory CMC specialist, Hyderabad is 8 to 12% cheaper. Bake the function mix into the city decision, not the other way around.
Explore further
Planning a GCC in Hyderabad?
Share your context and we will respond within one business day with a tailored blueprint. Or call/WhatsApp us right away.